Federation Of Pharmaceutical And Allied Products Merchant Exporters Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-12-2024
- Paid Up Capital ₹ 7.00 K
as on 23-12-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 33.30%
(FY 2022)
- Profit 29.73%
(FY 2022)
- Ebitda -69.03%
(FY 2022)
- Net Worth 43.30%
(FY 2022)
- Total Assets 40.14%
(FY 2022)
About Federation Of Pharmaceutical And Allied Products Merchant Exporters
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 7.00 K , as per Ministry of Corporate Affairs (MCA) records.
Yogesh Doshi, Niren Shah, Dhirendra Shah, and Four other members serve as directors at the Company.
- CIN/LLPIN
U85310MH2019NPL323402
- Company No.
323402
- Company Classification
Private Not For Profit Company
- Incorporation Date
30 Mar 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Federation Of Pharmaceutical And Allied Products Merchant Exporters?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Niren Shah  | Director | 02-Apr-2019 | Current |
| Yogesh Doshi | Director | 30-Mar-2019 | Current |
| Dhirendra Shah | Director | 30-Mar-2019 | Current |
| Hemal Shah | Director | 30-Mar-2019 | Current |
| Kamlesh Shah | Director | 30-Mar-2019 | Current |
| Sandeep Modi | Director | 30-Mar-2019 | Current |
Financial Performance of Federation Of Pharmaceutical And Allied Products Merchant Exporters.
Federation Of Pharmaceutical And Allied Products Merchant Exporters, for the financial year ended 2022, experienced significant growth in revenue, with a 33.3% increase. The company also saw a substantial improvement in profitability, with a 29.73% increase in profit. The company's net worth Soared by an impressive increase of 43.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Federation Of Pharmaceutical And Allied Products Merchant Exporters?
In 2022, Federation Of Pharmaceutical And Allied Products Merchant Exporters had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Federation Of Pharmaceutical And Allied Products Merchant Exporters?
Unlock and access historical data on people associated with Federation Of Pharmaceutical And Allied Products Merchant Exporters, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Federation Of Pharmaceutical And Allied Products Merchant Exporters, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Federation Of Pharmaceutical And Allied Products Merchant Exporters's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.